loadpatents
Patent applications and USPTO patent grants for DEHART; Jason.The latest application filed is for "rna replicon encoding a stabilized corona virus spike protein".
Patent | Date |
---|---|
SARS-CoV-2 Vaccines App 20210346492 - DEHART; Jason ;   et al. | 2021-11-11 |
RNA Replicon Encoding a Stabilized Corona Virus Spike Protein App 20210347828 - DEHART; Jason ;   et al. | 2021-11-11 |
Induce and enhance immune responses using recombinant replicon systems Grant 11,083,786 - Kamrud , et al. August 10, 2 | 2021-08-10 |
Hsv-1 Oncolytic Virus Therapies That Specifically Kill Alt Dependent Cancers App 20210220417 - O'Shea; Clodagh ;   et al. | 2021-07-22 |
Vaccines Based On Mutant Calr And Jak2 And Their Uses App 20210222133 - ATTAR; Ricardo ;   et al. | 2021-07-22 |
HSV-1 oncolytic virus therapies that specifically kill ALT dependent cancers Grant 10,821,141 - O'Shea , et al. November 3, 2 | 2020-11-03 |
Induce And Enhance Immune Responses Using Recombinant Replicon Systems App 20190224299 - Kamrud; Kurt Iver ;   et al. | 2019-07-25 |
Hsv-1 Oncolytic Virus Therapies That Specifically Kill Alt Dependent Cancers App 20190046594 - O'Shea; Clodagh ;   et al. | 2019-02-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.